During the past decade, Auburn Regional Center for Cancer Care conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 13 clinical trials were completed, i.e. on average, 216.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Auburn Regional Center for Cancer Care" #1 sponsor was "SWOG Cancer Research Network" with 15 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Auburn Regional Center for Cancer Care" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "American College of Surgeons" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Auburn Regional Center for Cancer Care" are "Breast Cancer" (10 trials), "Lung Cancer" (6 trials), "Ovarian Cancer" (4 trials), "Prostate Cancer" (3 trials) and "Fallopian Tube Cancer" (2 trials). Many other conditions were trialed in "Auburn Regional Center for Cancer Care" in a lesser frequency.

Most popular intervention types in "Auburn Regional Center for Cancer Care" are "Drug" (28 trials), "Biological" (8 trials), "Other" (8 trials), "Procedure" (5 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (6 trials), "Carboplatin" (4 trials), "cisplatin" (4 trials), "docetaxel" (4 trials) and "filgrastim" (4 trials). Other intervention names were less common.

The vast majority of trials in "Auburn Regional Center for Cancer Care" are 17 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Auburn Regional Center for Cancer Care". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Auburn Regional Center for Cancer Care, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Auburn Regional Center for Cancer Care, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".